Home › SEC Filings › Press Releases
Press Releases
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| WLDS | PRESS-RELEASE | neutral | 3/10 | Wearable Devices announced the Mudra Pro, a next-generation neural sensing wristband combining EMG, PPG, and IMU sensors | May 13, 2026 |
| BLNK | PRESS-RELEASE | neutral | 4/10 | Blink Charging reported Q1 2026 EPS of -$0.06, beating consensus of -$0.08 by 25%, while revenue of $24.6M was in line w | May 13, 2026 |
| BBWI | PRESS-RELEASE | neutral | 1/10 | Bath & Body Works, Inc. announced it will report its Q1 results on May 27, 2026. | May 13, 2026 |
| ASTC | PRESS-RELEASE | bearish | 7/10 | Astrotech reported Q3 FY2026 revenue of $343K, down 36% YoY from $534K, with a net loss of $3.77M ($2.25/share) vs $3.63 | May 13, 2026 |
| TTEC | PRESS-RELEASE | neutral | 3/10 | TTEC Digital announced a strategic collaboration agreement (SCA) with AWS to accelerate Amazon Connect adoption through | May 13, 2026 |
| SWMR | PRESS-RELEASE | bearish | 7/10 | Swarmer reported Q1 2026 revenue of $20,325, down 82% from $110,704 a year ago, and a net loss of $(4.5) million, widene | May 13, 2026 |
| TARA | PRESS-RELEASE | neutral | 4/10 | Protara Therapeutics reported Q1 2026 net loss of $0.31 per share, beating consensus estimates of $0.37 loss, with cash | May 13, 2026 |
| LIQT | PRESS-RELEASE | bearish | 6/10 | LiqTech reported Q1 2026 revenue of $4.1M (down 10.4% YoY) and EPS of $(0.28), missing consensus of $(0.21) by 33%. Net | May 13, 2026 |
| PLAB | PRESS-RELEASE | neutral | 1/10 | Photronics, Inc. announced it will report its fiscal Q2 2026 results on May 28, 2026. | May 13, 2026 |
| ALGM | PRESS-RELEASE | neutral | 2/10 | Allegro MicroSystems announced participation in TD Cowen's Technology, Media & Telecom Conference, a routine investor ev | May 13, 2026 |
| IPSC | PRESS-RELEASE | neutral | 4/10 | Century Therapeutics reported Q1 2026 EPS of -$0.11, beating the -$0.17 consensus by 35%, with zero revenue (in line). T | May 13, 2026 |
| SLXN | PRESS-RELEASE | bullish | 5/10 | Silexion Therapeutics announced initiation of GMP manufacturing of SIL204 with Catalent and ethics committee approval fo | May 13, 2026 |
| QUCY | PRESS-RELEASE | neutral | 3/10 | Quantum Cyber announced an exclusive IP license agreement with BP United Inc. for autonomous drone technology, including | May 13, 2026 |
| RENT | PRESS-RELEASE, 8-K | bearish | 6/10 | Co-founder and CEO Jennifer Hyman resigned effective May 15, 2026, and will serve as an advisor through January 2027. Bo | May 13, 2026 |
| ELBM | PRESS-RELEASE | neutral | 4/10 | Electra Battery Materials awarded a C$25 million construction contract to WB Melback Corporation for the solvent extract | May 13, 2026 |
| BCTXL | PRESS-RELEASE | neutral | 3/10 | BriaCell announced the addition of Penn Medicine's Abramson Cancer Center as a clinical trial site for its pivotal Phase | May 13, 2026 |
| PYPD | PRESS-RELEASE | bullish | 7/10 | PolyPid reported Q1 2026 net loss of $7.7M ($0.35/share), beating consensus EPS of -$0.43 by 18.6%. The company initiate | May 13, 2026 |
| NEXN | PRESS-RELEASE | bullish | 7/10 | Nexxen reported record Q1 2026 Contribution ex-TAC of $84.5M (+13% YoY) and programmatic revenue of $81.9M (+14% YoY), b | May 13, 2026 |
| ALT | PRESS-RELEASE | neutral | 5/10 | Altimmune reported Q1 2026 EPS of -$0.18, beating the -$0.25 consensus estimate by 28%, though revenue was $0 (vs $1K co | May 13, 2026 |
| ABUS | PRESS-RELEASE | bullish | 8/10 | Arbutus reported Q1 2026 GAAP EPS of $0.87 (diluted), a massive beat vs. consensus of -$0.06, driven by $178.7M in licen | May 13, 2026 |
| BWAY | PRESS-RELEASE | bullish | 8/10 | BrainsWay reported Q1 2026 revenue of $15.5M (+35% YoY) and net income of $2.3M (+107% YoY), both well above consensus e | May 13, 2026 |
| ABEO | PRESS-RELEASE | neutral | 5/10 | Abeona reported Q1 2026 net product revenue of $8.7M from ZEVASKYN, up from $2.4M in Q4 2025, with three patients treate | May 13, 2026 |
| KLRA | PRESS-RELEASE | neutral | 4/10 | Kailera Therapeutics and Hengrui Pharma announced two abstracts accepted for poster presentation at the ADA 2026 confere | May 13, 2026 |
| VSH | PRESS-RELEASE | mixed | 6/10 | Vishay reported Q1 2026 revenue of $839.2M (above $822.8M consensus) but GAAP EPS of $0.05 missed the $0.03 estimate on | May 13, 2026 |
| ALT | PRESS-RELEASE | bullish | 6/10 | Altimmune announced that its 48-week IMPACT Phase 2b data for pemvidutide in MASH has been selected for 'Best of EASL 20 | May 13, 2026 |
| MIST | PRESS-RELEASE | neutral | 5/10 | Milestone Pharmaceuticals reported Q1 2026 results with first-ever product revenue of $0.2M from CARDAMYST launch, but n | May 13, 2026 |
| GILT | PRESS-RELEASE | bullish | 7/10 | Gilat reported Q1 2026 revenue of $110.5M (+20% YoY) and GAAP EPS of $0.07, swinging from a $0.11 loss in Q1 2025. Non-G | May 13, 2026 |
| TSEM | PRESS-RELEASE | bullish | 8/10 | Tower Semiconductor reported a strong Q1 2026 beat with EPS of $0.58 (GAAP basic) vs $0.56 consensus and revenue of $414 | May 13, 2026 |
| CTW | PRESS-RELEASE | bearish | 6/10 | CTW reported 1H26 revenue of $40.9M (-1% YoY) and a net loss of $1.2M vs. net income of $0.6M a year ago, while Adjusted | May 13, 2026 |
| UPB | PRESS-RELEASE | bearish | 6/10 | Upstream Bio reported Q1 2026 EPS of -$0.79, missing consensus of -$0.75 by 5.3%, with net loss widening to $40.6M from | May 13, 2026 |